Neuropsychological Performance in Older Patients With Schizophrenia: A Meta-Analysis of Cross-sectional and Longitudinal Studies

Abstract

Objective: Cognitive deficits are among the most reliable predictors of functional impairment in schizophrenia and a particular concern for older individuals with schizophrenia. Previous reviews have focused on the nature and course of cognitive impairments in younger cohorts, but a quantitative meta-analysis in older patients is pending. Method: A previously used search strategy identified studies assessing performance on tests of global cognition and specific neuropsychological domains in older patients with schizophrenia and age-matched comparison groups. Both crosssectional and longitudinal studies were included. Potential methodological, demographic, and clinical moderators were analyzed. Results: Twenty-nine cross-sectional (2110 patients, 1738 comparison subjects) and 14 longitudinal (954 patients) studies met inclusion criteria. Patients were approximately 65 years old, with 11 years of education, 53% male and 79% Caucasian. Longitudinal analysis (range 1-6 years) revealed homogeneity with small effect sizes (d 5 20.097) being observed. Cross-sectional analyses revealed large and heterogeneous deficits in global cognition (d 5 21.19) and on specific neuropsychological tests (d 5 20.7 to 21.14). Moderator analysis revealed a significant role for demographic (age, sex, education, race) and clinical factors (diagnosis, inpatient status, age of onset, duration of illness, positive and negative symptomology). Medication status (medicated vs nonmedicated) and chlorpromazine equivalents were inconsequential, albeit underrepresented. Conclusions: Large and generalized cognitive deficits in older individuals with schizophrenia represent a robust finding paralleling impairments across the life span, but these deficits do not decline over a 1-6 year period. The importance of considering demographic and clinical moderators in cross-sectional analyses is highlighted.

Medial frontal gyrus alterations in schizophrenia: Relationship with duration of illness and executive dysfunction

“…Although some research groups found evidence of progressive impairment in executive function in relation to illness course, others described a static nature of the cognitive deficit in schizophrenia (Freedman and Brown, 2011). Most of the earlier reviews and meta-analyses considered executive dysfunctions as a core feature of schizophrenia, present at the onset of the disorder and remaining stable over the course of the illness (Szoke et al, 2008;Irani et al, 2011;Bora and Murray, 2014). Our results are not consistent with previous findings, as we observed an association between WCST performance and illness duration.…”

“…However, given that this study considered together both WCST and Halstead Category Test performances, these differences are difficult to interpret. Another recent meta-analysis (Irani et al, 2011) reported that greater global cognitive impairment was associated with shorter DoI and that later age of onset was not associated with specific neuropsychological domains. There was not a specific analysis for WCST.…”

A neurodevelopment and neuroplasticity-based framework for early intervention in psychotic disorders

“…However, longitudinal neuropsychological studies in first-episode and established schizophrenia and UHR have not found evidence of cumulative cognitive decline (Szöke et al 2008;Bonner-Jackson et al 2010;Irani et al 2011;Bora & Murray, 2014). In these patient samples, cognitive deficits are stable or even slightly improved at follow-up.…”

Liberty or dignity: community treatment orders and rights

“…This would argue that a system should be in place to ensure that a patient can get the treatment that they require, even if they do not consent. It could be argued that the use of CTOs provides such a mechanism and aids in preventing the patient from becoming a victim of their own illness, owing to a repeating pattern of illness relapse, deterioration in social functioning and residual cognitive impairment (Heaton et al 2001;Irani et al 2011). The use of a beneficence approach holds the patients' best interests as a central tenet in deciding the most appropriate treatment programme for them to allow for the restoration of their decision-making capacity.…”